| Autor: |
Ashton WT; Department of Medicinal Chemistry, Merck Research Laboratories, PO Box 2000, 07065-0900, Rahway, NJ, USA. wally_ashton@merck.com, Sisco RM, Yang YT, Lo JL, Yudkovitz JB, Gibbons PH, Mount GR, Ren RN, Butler BS, Cheng K, Goulet MT |
| Jazyk: |
angličtina |
| Zdroj: |
Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2001 Jul 09; Vol. 11 (13), pp. 1727-31. |
| DOI: |
10.1016/s0960-894x(01)00275-x |
| Abstrakt: |
A pyridine side-chain terminus has been incorporated into the indole-5-carboxamide and indole-5-acetamide series of GnRH antagonists. Potent activity was observed in binding and functional assays. Certain branched or cyclic tertiary amides were identified as preferred in each series. Alkylation of the side-chain secondary amine had generally unfavorable effects. Variations of the gem-dialkyl substituents in the indole-5-acetamide series were also investigated. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
Full Text from ScienceDirect